Header
Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
Sie suchen in allen Bereichen nach dem Autor Nakad R.
In der Rubrik Zeitschriften haben wir 2 Beiträge für Sie gefunden
-
MerkenSafety profiles of EU-approved COVID-19 vaccines
Rubrik: Arzneimittelwesen
(Treffer aus pharmind, Nr. 02, Seite 164 (2022))
Safety profiles of EU-approved COVID-19 vaccines / What we know so far – Part 2*Part 1 of this article see Pharm. Ind. 2021;83(12):1563–1572. · Nakad R, Fischer B · SCRATCH Pharmacovigilance GmbH & Co. KG, Butzbach
In Apr. 2021, the EMA began to analyse the occurrence of capillary leak syndrome after vaccination with Vaxzevria. Capillary leak syndrome (CLS) is a rare disorder with massive, disseminated leakage of fluid from the small blood vessels and capillaries into the surrounding tissue leading to a rapid drop of blood pressure and tissue swelling accompanied by haemoconcentration and hypalbuminaemia [ 77 ], possibly manifesting in a life-threatening condition with hypovolemic shock and multiple organ failure [ 78 ]. 5 cases had been reported at that time to the European safety database EudraVigilance with 34 Mio. doses of Vaxzevria administered [ 53 ]. ...
-
Merken
Safety profiles of EU-approved COVID-19 vaccines
Rubrik: Arzneimittelwesen
(Treffer aus pharmind, Nr. 12, Seite 1563 (2021))
Safety profiles of EU-approved COVID-19 vaccines / What we know so far – Part 1 · Nakad R, Fischer B · SCRATCH Pharmacovigilance GmbH & Co. KG, Butzbach
Die Sicherheitsprofile der in der EU zugelassenen COVID-19-Impfstoffe
